RNA Annual CFO
-$119.06 M
+$17.20 M+12.63%
31 December 2023
Summary:
As of January 23, 2025, RNA annual cash flow from operations is -$119.06 million, with the most recent change of +$17.20 million (+12.63%) on December 31, 2023. During the last 3 years, it has fallen by -$81.95 million (-220.78%). RNA annual CFO is now -4881.69% below its all-time high of $2.49 million, reached on December 31, 2019.RNA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNA Quarterly CFO
-$65.61 M
-$611.00 K-0.94%
01 September 2024
Summary:
As of January 23, 2025, RNA quarterly cash flow from operations is -$65.61 million, with the most recent change of -$611.00 thousand (-0.94%) on September 1, 2024. Over the past year, it has dropped by -$28.82 million (-78.35%). RNA quarterly CFO is now -497.64% below its all-time high of $16.50 million, reached on December 31, 2023.RNA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNA TTM CFO
-$184.50 M
-$28.82 M-18.52%
01 September 2024
Summary:
As of January 23, 2025, RNA TTM cash flow from operations is -$184.50 million, with the most recent change of -$28.82 million (-18.52%) on September 1, 2024. Over the past year, it has dropped by -$9.74 million (-5.58%). RNA TTM CFO is now -1477.47% below its all-time high of $13.39 million, reached on June 30, 2019.RNA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.6% | -78.3% | -5.6% |
| 3 y3 years | -220.8% | -215.7% | -125.9% |
| 5 y5 years | -1133.2% | -1015.0% | -7509.6% |
RNA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.6% | +12.6% | -497.6% | +6.8% | -94.6% | at low |
| 5 y | 5-year | -4881.7% | +12.6% | -497.6% | +6.8% | -7509.6% | at low |
| alltime | all time | -4881.7% | +12.6% | -497.6% | +6.8% | -1477.5% | at low |
Avidity Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$65.61 M(+0.9%) | -$184.50 M(+18.5%) |
| June 2024 | - | -$65.00 M(-7.6%) | -$155.67 M(+10.8%) |
| Mar 2024 | - | -$70.38 M(-526.5%) | -$140.48 M(+18.0%) |
| Dec 2023 | -$119.06 M(-12.6%) | $16.50 M(-144.9%) | -$119.06 M(-31.9%) |
| Sept 2023 | - | -$36.79 M(-26.1%) | -$174.75 M(+2.8%) |
| June 2023 | - | -$49.81 M(+1.7%) | -$169.92 M(+9.2%) |
| Mar 2023 | - | -$48.97 M(+25.0%) | -$155.66 M(+14.2%) |
| Dec 2022 | -$136.27 M(+43.7%) | -$39.19 M(+22.6%) | -$136.27 M(+10.5%) |
| Sept 2022 | - | -$31.96 M(-10.1%) | -$123.29 M(+10.0%) |
| June 2022 | - | -$35.55 M(+20.2%) | -$112.12 M(+7.1%) |
| Mar 2022 | - | -$29.57 M(+12.8%) | -$104.71 M(+10.4%) |
| Dec 2021 | -$94.81 M | -$26.21 M(+26.1%) | -$94.81 M(+16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$20.78 M(-26.1%) | -$81.67 M(+16.7%) |
| June 2021 | - | -$28.14 M(+43.0%) | -$70.00 M(+41.0%) |
| Mar 2021 | - | -$19.68 M(+50.5%) | -$49.66 M(+33.8%) |
| Dec 2020 | -$37.12 M(-1590.6%) | -$13.07 M(+43.5%) | -$37.12 M(+27.7%) |
| Sept 2020 | - | -$9.11 M(+17.0%) | -$29.06 M(+12.5%) |
| June 2020 | - | -$7.79 M(+9.1%) | -$25.84 M(+907.6%) |
| Mar 2020 | - | -$7.14 M(+42.3%) | -$2.56 M(-203.0%) |
| Dec 2019 | $2.49 M(-125.8%) | -$5.02 M(-14.7%) | $2.49 M(-66.8%) |
| Sept 2019 | - | -$5.88 M(-138.0%) | $7.51 M(-43.9%) |
| June 2019 | - | $15.48 M(-842.1%) | $13.39 M(-742.1%) |
| Mar 2019 | - | -$2.09 M | -$2.09 M |
| Dec 2018 | -$9.65 M | - | - |
FAQ
- What is Avidity Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Avidity Biosciences?
- What is Avidity Biosciences annual CFO year-on-year change?
- What is Avidity Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Avidity Biosciences?
- What is Avidity Biosciences quarterly CFO year-on-year change?
- What is Avidity Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Avidity Biosciences?
- What is Avidity Biosciences TTM CFO year-on-year change?
What is Avidity Biosciences annual cash flow from operations?
The current annual CFO of RNA is -$119.06 M
What is the all time high annual CFO for Avidity Biosciences?
Avidity Biosciences all-time high annual cash flow from operations is $2.49 M
What is Avidity Biosciences annual CFO year-on-year change?
Over the past year, RNA annual cash flow from operations has changed by +$17.20 M (+12.63%)
What is Avidity Biosciences quarterly cash flow from operations?
The current quarterly CFO of RNA is -$65.61 M
What is the all time high quarterly CFO for Avidity Biosciences?
Avidity Biosciences all-time high quarterly cash flow from operations is $16.50 M
What is Avidity Biosciences quarterly CFO year-on-year change?
Over the past year, RNA quarterly cash flow from operations has changed by -$28.82 M (-78.35%)
What is Avidity Biosciences TTM cash flow from operations?
The current TTM CFO of RNA is -$184.50 M
What is the all time high TTM CFO for Avidity Biosciences?
Avidity Biosciences all-time high TTM cash flow from operations is $13.39 M
What is Avidity Biosciences TTM CFO year-on-year change?
Over the past year, RNA TTM cash flow from operations has changed by -$9.74 M (-5.58%)